1-7 of 7
Shai Shimony
Close
Sort by
Journal Articles

Intensive Induction Chemotherapy versus Hypomethylating Agents in Combination with Venetoclax in NPM1-mutant AML

Jan Philipp Bewersdorf, Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva Johanna Schaefer, Amer M. Zeidan, Aaron D Goldberg, Eytan M. Stein, Guido Marcucci, Rebecca Bystrom, R. Coleman Lindsley, Evan C. Chen, Jorge Miguel Ramos Perez, Anthony S. Stein, Vinod A Pullarkat, Ibrahim Aldoss, Daniel J DeAngelo, Donna S. Neuberg, Richard M. Stone, Sylvain Garciaz, Brian J. Ball, Maximilian Stahl
Journal: Blood Advances
Blood Adv bloodadvances.2024012858.
https://doi.org/10.1182/bloodadvances.2024012858
Published: 2024
Includes: Supplemental data
Journal Articles

Organ involvement in adults with BPDCN is associated with sun exposure history, TET2 and RAS mutations, and survival

Shai Shimony, Julia Keating, Christopher J. Fay, Marlise R. Luskin, Donna S. Neuberg, Nicole R. LeBoeuf, Andrew A. Lane
Journal: Blood Advances
Blood Adv (2024) 8 (11): 2803–2812.
https://doi.org/10.1182/bloodadvances.2024012797
Published: 2024
Includes: Supplemental data
Journal Articles

Nelarabine: when and how to use in the treatment of T-cell acute lymphoblastic leukemia

Shai Shimony, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood Advances
Blood Adv (2023) 8 (1): 23–36.
https://doi.org/10.1182/bloodadvances.2023010303
Published: 2023
Journal Articles

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years

Clinical Trials & Observations
Shai Shimony, Geoffrey Fell, Evan C. Chen, Harrison K. Tsai, Martha Wadleigh, Eric S. Winer, Jacqueline S. Garcia, Marlise R. Luskin, Maximilian Stahl, Donna S. Neuberg, Daniel J. DeAngelo, R. Coleman Lindsley, Richard M. Stone
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5354–5358.
https://doi.org/10.1182/bloodadvances.2023009748
Published: 2023
Includes: Supplemental data
Journal Articles

Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials

Clinical Trials & Observations
Shai Shimony, Yael Flamand, Yannis K. Valtis, Andrew E. Place, Lewis B. Silverman, Lynda M. Vrooman, Andrew M. Brunner, Stephen E. Sallan, Richard M. Stone, Martha Wadleigh, Donna S. Neuberg, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood Advances
Blood Adv (2023) 7 (18): 5234–5245.
https://doi.org/10.1182/bloodadvances.2023009976
Published: 2023
Includes: Supplemental data
Journal Articles

Nelarabine combination therapy for relapsed or refractory T-cell acute lymphoblastic lymphoma/leukemia

Clinical Trials & Observations
Shai Shimony, Yiwen Liu, Yannis K. Valtis, Jonathan D. Paolino, Andrew E. Place, Andrew M. Brunner, Lachelle D. Weeks, Lewis B. Silverman, Lynda M. Vrooman, Donna S. Neuberg, Richard M. Stone, Daniel J. DeAngelo, Marlise R. Luskin
Journal: Blood Advances
Blood Adv (2023) 7 (7): 1092–1102.
https://doi.org/10.1182/bloodadvances.2022008280
Published: 2023
Includes: Supplemental data
Journal Articles

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Jurjen Versluis, Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Mark Faber, Rahul S. Vedula, Anne Charles, Kevin M. Copson, Shai Shimony, Alon Rozental, Pavan K. Bendapudi, Ofir Wolach, Elizabeth A. Griffiths, James E. Thompson, Richard M. Stone, Daniel J. DeAngelo, Donna Neuberg, Marlise R. Luskin, Eunice S. Wang, R. Coleman Lindsley
Journal: Blood Advances
Blood Adv (2022) 6 (9): 2835–2846.
https://doi.org/10.1182/bloodadvances.2021006166
Published: 2022
Includes: Supplemental data